Search
Searching Goglides
Loading matching companies, research, topics, and discussions.
Searching Goglides
Loading matching companies, research, topics, and discussions.
Search uses Goglides API results from the projection-backed discovery index. Private, draft, hidden, unpublished, and admin-only content stays out of public results.
Showing public results only.
SEC filings, financial facts, source resources, and Goglides workspace context for Thermo Fisher Scientific Inc..
Signed-in searches appear here after you use search.
Tag facets appear after tag usage counts are rebuilt.
A hidden-identity GoGlides receipts explainer on Filtronic, profitability, cash, SpaceX orders, and customer-concentration risk.
OpenA hidden-identity GoGlides receipts explainer on Redwire's backlog, defense-UAS wins, cash flow, and dilution risk.
OpenA hidden-identity GoGlides receipts explainer on Sidus Space, balance sheet strength, small revenue, and dilution risk.
OpenThermo Fisher's acquisition engine is still powerful, but Q1 2026 showed why the premium-multiple debate needs a harder evidence gate: 6% reported revenue growth, 1% organic growth, a major Clario acquisition, higher debt and a larger goodwill/intangible asset
OpenThermo Fisher and Agilent both use service ecosystems, but capital allocation decides which model compounds better.
OpenThermo Fisher reported 2025 revenue of $44.6 billion and Q1 2026 revenue of $11.0 billion. The thesis depends on biopharma demand, instrument and consumables mix, diagnostics normalization, margin durability, M&A integration and cash conversion.
OpenA hidden-identity GoGlides receipts explainer on Momentus, the space tow-truck idea, cash, losses, and dilution risk.
OpenMomentus says its cash position has jumped to about $76 million with no debt. The real question is whether Vigoride progress can become revenue before share-count math absorbs the upside.
OpenTag facets appear after tag usage counts are rebuilt.